| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anticoagulation in COVID-19: reaction to the ACTION trial
|
Berger, Jeffrey S
|
|
|
397 |
10291 |
p. 2226-2228
|
artikel
|
| 2 |
A strategy for SARS-CoV-2 vaccination in Yemen
|
Nasser, Abdullah
|
|
|
397 |
10291 |
p. 2247
|
artikel
|
| 3 |
Cardiovascular risk prediction in type 2 diabetes before and after widespread screening: a derivation and validation study
|
Pylypchuk, Romana
|
|
|
397 |
10291 |
p. 2264-2274
|
artikel
|
| 4 |
ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates
|
McQuade, Elizabeth T Rogawski
|
|
|
397 |
10291 |
p. 2247-2248
|
artikel
|
| 5 |
ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates – Authors' reply
|
Voysey, Merryn
|
|
|
397 |
10291 |
p. 2248
|
artikel
|
| 6 |
China's three-child policy
|
Tatum, Megan
|
|
|
397 |
10291 |
p. 2238
|
artikel
|
| 7 |
Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial
|
Visser, Margaretha M
|
|
|
397 |
10291 |
p. 2275-2283
|
artikel
|
| 8 |
COVID-19 vaccine efficacy data: solid enough to delay second dose?
|
Robertson, John F R
|
|
|
397 |
10291 |
p. 2248-2249
|
artikel
|
| 9 |
COVID-19 vaccine efficacy data: solid enough to delay second dose? – Authors' reply
|
Amit, Sharon
|
|
|
397 |
10291 |
p. 2249-2250
|
artikel
|
| 10 |
Department of Error
|
|
|
|
397 |
10291 |
p. 2252
|
artikel
|
| 11 |
Department of Error
|
|
|
|
397 |
10291 |
p. 2252
|
artikel
|
| 12 |
Department of Error
|
|
|
|
397 |
10291 |
p. 2252
|
artikel
|
| 13 |
Inclusion and diversity in the PRINCIPLE trial
|
Patel, Mahendra G
|
|
|
397 |
10291 |
p. 2251-2252
|
artikel
|
| 14 |
India's resurgence of COVID-19: urgent actions needed
|
Aiyar, Yamini
|
|
|
397 |
10291 |
p. 2232-2234
|
artikel
|
| 15 |
Intersectionality in UHC: from blue-sky to day-to-day practice
|
Ghasemi, Elham
|
|
|
397 |
10291 |
p. 2252
|
artikel
|
| 16 |
Is reimbursement for alerts and real-time continuous glucose monitoring needed?
|
Nørgaard, Kirsten
|
|
|
397 |
10291 |
p. 2230-2232
|
artikel
|
| 17 |
José Baselga
|
Watts, Geoff
|
|
|
397 |
10291 |
p. 2246
|
artikel
|
| 18 |
Kirsten Ostherr: mobilising the translational humanities
|
McLellan, Faith
|
|
|
397 |
10291 |
p. 2243
|
artikel
|
| 19 |
Narrative complexity in the time of COVID-19
|
Gubrium, Aline
|
|
|
397 |
10291 |
p. 2244-2245
|
artikel
|
| 20 |
Parkinson's disease
|
Bloem, Bastiaan R
|
|
|
397 |
10291 |
p. 2284-2303
|
artikel
|
| 21 |
Political change in Israel and the effects on health
|
Devi, Sharmila
|
|
|
397 |
10291 |
p. 2237
|
artikel
|
| 22 |
SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties
|
Oliu-Barton, Miquel
|
|
|
397 |
10291 |
p. 2234-2236
|
artikel
|
| 23 |
Southern Madagascar faces “shocking” lack of food
|
Makoni, Munyaradzi
|
|
|
397 |
10291 |
p. 2239
|
artikel
|
| 24 |
Tension pericardial abscess in a patient with tuberculosis: a rare cause of cardiac tamponade
|
Deshpande, Amit Ajit
|
|
|
397 |
10291 |
p. e15
|
artikel
|
| 25 |
The public health approach to paediatric firearm injury
|
Ranney, Megan L
|
|
|
397 |
10291 |
p. 2241-2242
|
artikel
|
| 26 |
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial
|
Lopes, Renato D
|
|
|
397 |
10291 |
p. 2253-2263
|
artikel
|
| 27 |
US–China health exchange and collaboration following COVID-19
|
Li, Liming
|
|
|
397 |
10291 |
p. 2304-2308
|
artikel
|
| 28 |
US drug importation plan hits snag
|
Jaffe, Susan
|
|
|
397 |
10291 |
p. 2240
|
artikel
|
| 29 |
Vaccines can save children with non-preventable diseases
|
Saha, Senjuti
|
|
|
397 |
10291 |
p. 2250
|
artikel
|
| 30 |
Vaccines can save children with non-preventable diseases – Authors' reply
|
Gaythorpe, Katy A M
|
|
|
397 |
10291 |
p. 2251
|
artikel
|
| 31 |
We need a global conversation on the 2020 Olympic Games
|
The Lancet,
|
|
|
397 |
10291 |
p. 2225
|
artikel
|
| 32 |
Widespread diabetes screening for cardiovascular disease risk estimation
|
Arnett, Donna K
|
|
|
397 |
10291 |
p. 2228-2230
|
artikel
|
Tijdschrift beschrijving